[1]
2020. Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer. Farmeconomia. Health economics and therapeutic pathways. 21, 1 (Feb. 2020). DOI:https://doi.org/10.7175/fe.v21i1.1450.